InMed Pharmaceuticals Inc. (INM) vs Skye Bioscience, Inc. (SKYE)
A side-by-side comparison of InMed Pharmaceuticals Inc. and Skye Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
SKYE
Skye Bioscience, Inc.
$1.65HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — INM vs SKYE
growth of $100 · dividends reinvested · last 10yINM -99.9% (-52.7%/yr)SKYE -99.8% (-47.3%/yr)SKYE compounded faster over this window
INM SKYE
INM vs SKYE: by the numbers
- •INM is the larger company ($7M vs $7M market cap).
- •Both run net losses; SKYE's is the smaller (0.00% vs -0.61% net margin).
Metrics side by side
Valuation
| Metric | INM | SKYE |
|---|---|---|
| P/S ratio | 0.00 | N/A |
| P/B ratio | 6.80 | N/A |
Profitability
| Metric | INM | SKYE |
|---|---|---|
| Gross margin | 14.92% | 0.00% |
| Operating margin | -0.52% | 0.00% |
| Net margin | -0.61% | 0.00% |
| ROE | -1168.44% | N/A |
| ROIC | -995.44% | N/A |
Growth (annualized)
| Metric | INM | SKYE |
|---|---|---|
| Total return CAGR (5Y) | -71.98% | -60.42% |
Frequently asked
- How have INM and SKYE total returns compared?
- Over the past 10 years, INM delivered -52.81% and SKYE delivered -46.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.